Product Pipeline

4SC’s product pipeline is currently comprised of six compounds in various stages of clinical and preclinical development as well as several research programmes. Two compounds are currently in several Phase II trials, three are in Phase I trials and one compound is in formal preclinical development. After a successful proof-of-concept we intend to enter into partnering and commercialisation deals with international biotech and pharmaceutical companies.

Please click to enlarge